{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:13:44Z","timestamp":1762542824849},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s13402-018-0379-3","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T07:55:38Z","timestamp":1523260538000},"page":"335-341","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genetics of personalized medicine: cancer and rare diseases"],"prefix":"10.1007","volume":"41","author":[{"given":"In\u00eas Teles Siefers","family":"Alves","sequence":"first","affiliation":[]},{"given":"Manuel","family":"Condinho","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Cust\u00f3dio","sequence":"additional","affiliation":[]},{"given":"Bruna F.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"V\u00e2nia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Paulo J.","family":"da Costa","sequence":"additional","affiliation":[]},{"given":"Rafaela","family":"Lacerda","sequence":"additional","affiliation":[]},{"given":"Ana Rita","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Martins-Dias","sequence":"additional","affiliation":[]},{"given":"Gon\u00e7alo R.","family":"Nogueira","sequence":"additional","affiliation":[]},{"given":"Ana Rita","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Pinho","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Rolo","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Travessa","sequence":"additional","affiliation":[]},{"given":"Ros\u00e1rio Pinto","family":"Leite","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Rom\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"379_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"E.T. Wang, R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang, C. Mayr, S.F. Kingsmore, G.P. Schroth, C.B. Burge, Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470\u2013476 (2008)","journal-title":"Nature"},{"key":"379_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ng.259","volume":"40","author":"Q Pan","year":"2008","unstructured":"Q. Pan, O. Shai, L.J. Lee, B.J. Frey, B.J. Blencowe, Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40, 1413\u20131415 (2008)","journal-title":"Nat. Genet."},{"key":"379_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/418236a","volume":"418","author":"T Maniatis","year":"2002","unstructured":"T. Maniatis, B. Tasic, Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418, 236\u2013243 (2002)","journal-title":"Nature"},{"key":"379_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ceb.2005.04.006","volume":"17","author":"DL Bentley","year":"2005","unstructured":"D.L. Bentley, Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol. 17, 251\u2013256 (2005)","journal-title":"Curr. Opin. Cell Biol."},{"key":"379_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0092-8674(00)80925-3","volume":"92","author":"JP Staley","year":"1998","unstructured":"J.P. Staley, C. Guthrie, Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell 92, 315\u2013326 (1998)","journal-title":"Cell"},{"key":"379_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature01031","volume":"419","author":"Z Zhou","year":"2002","unstructured":"Z. Zhou, L.J. Licklider, S.P. Gygi, R. Reed, Comprehensive proteomic analysis of the human spliceosome. Nature 419, 182\u2013185 (2002)","journal-title":"Nature"},{"key":"379_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biocel.2017.07.013","volume":"91","author":"PJ Costa da","year":"2017","unstructured":"P.J. da Costa, J. Menezes, L. Rom\u00e3o, The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease. Int. J. Biochem. Cell Biol. 91, 168\u2013175 (2017). \n                    https:\/\/doi.org\/10.1016\/j.biocel.2017.07.013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"379_CR8","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1101\/gad.1973010","volume":"24","author":"CJ David","year":"2010","unstructured":"C.J. David, J.L. Manley, Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343\u20132364 (2010)","journal-title":"Genes Dev."},{"key":"379_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-015-0266-0","volume":"39","author":"B Sumithra","year":"2016","unstructured":"B. Sumithra, U. Saxena, A.B. Das, Alternative splicing within the Wnt signaling pathway: role in cancer development. Cell. Oncol. 39, 1\u201313 (2016)","journal-title":"Cell. Oncol."},{"key":"379_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","volume":"150","author":"M Imielinski","year":"2012","unstructured":"M. Imielinski, A.H. Berger, P.S. Hammerman, B. Hernandez, T.J. Pugh, E. Hodis, J. Cho, J. Suh, M. Capelletti, A. Sivachenko, C. Sougnez, D. Auclair, M.S. Lawrence, P. Stojanov, K. Cibulskis, K. Choi, L. de Waal, T. Sharifnia, A. Brooks, H. Greulich, S. Banerji, T. Zander, D. Seidel, F. Leenders, S. Ans\u00e9n, C. Ludwig, W. Engel-Riedel, E. Stoelben, J. Wolf, C. Goparju, K. Thompson, W. Winckler, D. Kwiatkowski, B.E. Johnson, P.A. J\u00e4nne, V.A. Miller, W. Pao, W.D. Travis, H.I. Pass, S.B. Gabriel, E.S. Lander, R.K. Thomas, L.A. Garraway, G. Getz, M. Meyerson, Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107\u20131120 (2012)","journal-title":"Cell"},{"key":"379_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/15476286.2016.1144004","volume":"13","author":"J Hern\u00e1ndez","year":"2016","unstructured":"J. Hern\u00e1ndez, E. Bechara, D. Schlesinger, J. Delgado, L. Serrano, J. Valc\u00e1rcel, Tumor suppressor properties of the splicing regulatory factor RBM10. RNA Biol. 13, 466\u2013472 (2016)","journal-title":"RNA Biol."},{"key":"379_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.molcel.2013.11.010","volume":"52","author":"EG Bechara","year":"2013","unstructured":"E.G. Bechara, E. Sebesty\u00e9n, I. Bernardis, E. Eyras, J. Valc\u00e1rcel, RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol. Cell 52, 720\u2013733 (2013)","journal-title":"Mol. Cell"},{"key":"379_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ccell.2016.10.004","volume":"30","author":"L Wurth","year":"2016","unstructured":"L. Wurth, P. Papasaikas, D. Olmeda, N. Bley, G.T. Calvo, S. Guerrero, D. Cerezo-Wallis, J. Martinez-Useros, M. Garc\u00eda-Fern\u00e1ndez, S. H\u00fcttelmaier, M.S. Soengas, F. Gebauer, UNR\/CSDE1 drives a post-transcriptional program to promote melanoma invasion and metastasis. Cancer Cell 30, 694\u2013707 (2016)","journal-title":"Cancer Cell"},{"key":"379_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/wsbm.54","volume":"2","author":"AR Morris","year":"2010","unstructured":"A.R. Morris, N. Mukherjee, J.D. Keene, Systematic analysis of posttranscriptional gene expression. Wiley Interdiscip. Rev. Syst. Biol. Med. 2, 162\u2013180 (2010)","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"379_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbagrm.2014.10.001","volume":"1849","author":"L Wurth","year":"2015","unstructured":"L. Wurth, F. Gebauer, RNA-binding proteins, multifaceted translational regulators in cancer. Biochim. Biophys. Acta-Gene Regul. Mech. 1849, 881\u2013886 (2015)","journal-title":"Biochim. Biophys. Acta-Gene Regul. Mech."},{"key":"379_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2014.10.030","volume":"57","author":"P Papasaikas","year":"2015","unstructured":"P. Papasaikas, J.R. Tejedor, L. Vigevani, J. Valc\u00e1rcel, Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery. Mol. Cell 57, 7\u201322 (2015)","journal-title":"Mol. Cell"},{"key":"379_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10969-010-9081-z","volume":"11","author":"AK Goroncy","year":"2010","unstructured":"A.K. Goroncy, S. Koshiba, N. Tochio, T. Tomizawa, M. Inoue, S. Watanabe, T. Harada, A. Tanaka, O. Ohara, T. Kigawa, S. Yokoyama, The NMR solution structures of the five constituent cold-shock domains (CSD) of the human UNR (upstream of N-ras) protein. J. Struct. Funct. Genom. 11, 181\u2013188 (2010)","journal-title":"J. Struct. Funct. Genom."},{"key":"379_CR18","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/nar\/27.8.1926","volume":"27","author":"G Triqueneaux","year":"1999","unstructured":"G. Triqueneaux, M. Velten, P. Franzon, F. Dautry, H. Jacquemin-Sablon, RNA binding specificity of Unr, a protein with five cold shock domains. Nucleic Acids Res. 27, 1926\u20131934 (1999)","journal-title":"Nucleic Acids Res."},{"key":"379_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/bj3390657","volume":"339","author":"D Huang","year":"1999","unstructured":"D. Huang, H. Pospiech, T. Kesti, J.E. Syva, Structural organization and splice variants of the POLE1 gene encoding the catalytic subunit of human DNA polymerase \u03b5. Biochem. J. 339, 657\u2013665 (1999)","journal-title":"Biochem. J."},{"key":"379_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ng.2503","volume":"45","author":"C Palles","year":"2013","unstructured":"C. Palles, J.B. Cazier, K.M. Howarth, E. Domingo, A.M. Jones, P. Broderick, Z. Kemp, S.L. Spain, E.G. Almeida, I. Salguero, A. Sherborne, D. Chubb, L.G. Carvajal-Carmona, Y. Ma, K. Kaur, S. Dobbins, E. Barclay, M. Gorman, L. Martin, M.B. Kovac, S. Humphray, A. Lucassen, C.C. Holmes, D. Bentley, P. Donnelly, J. Taylor, C. Petridis, R. Roylance, E.J. Sawyer, D.J. Kerr, S. Clark, J. Grimes, S.E. Kearsey, H.J.W. Thomas, G. McVean, R.S. Houlston, I. Tomlinson, Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat. Genet. 45, 136\u2013144 (2013)","journal-title":"Nat. Genet."},{"key":"379_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s13402-016-0284-6","volume":"39","author":"MM Hahn","year":"2016","unstructured":"M.M. Hahn, R.M. de Voer, N. Hoogerbrugge, M.J.L. Ligtenberg, R.P. Kuiper, A. Geurts van Kessel, The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery. Cell. Oncol. 39, 491\u2013510 (2016)","journal-title":"Cell. Oncol."},{"key":"379_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11883","volume":"7","author":"D Chubb","year":"2016","unstructured":"D. Chubb, P. Broderick, S.E. Dobbins, M. Frampton, B. Kinnersley, S. Penegar, A. Price, Y.P. Ma, A.L. Sherborne, C. Palles, M.N. Timofeeva, D.T. Bishop, M.G. Dunlop, I. Tomlinson, R.S. Houlston, Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. Nat. Commun. 7, 11883 (2016)","journal-title":"Nat. Commun."},{"key":"379_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s13402-016-0309-1","volume":"40","author":"K Bairi El","year":"2017","unstructured":"K. El Bairi, A.H. Kandhro, A. Gouri, W. Mahfoud, N. Louanjli, B. Saadani, S. Afqir, M. Amrani, Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer. Cell. Oncol. 40, 105\u2013118 (2017)","journal-title":"Cell. Oncol."},{"key":"379_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-016-0297-1","volume":"40","author":"A Chavez-Gonzalez","year":"2017","unstructured":"A. Chavez-Gonzalez, B. Bakhshinejad, K. Pakravan, M.L. Guzman, S. Babashah, Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer. Cell. Oncol. 40, 1\u201320 (2017)","journal-title":"Cell. Oncol."},{"key":"379_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13402-017-0345-5","volume":"40","author":"M Yousefi","year":"2017","unstructured":"M. Yousefi, T. Bahrami, A. Salmaninejad, R. Nosrati, P. Ghaffari, S.H. Ghaffari, Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options. Cell. Oncol. 40, 419\u2013441 (2017)","journal-title":"Cell. Oncol."},{"key":"379_CR26","doi-asserted-by":"publisher","first-page":"22606","DOI":"10.18632\/oncotarget.15146","volume":"8","author":"PO Pietarinen","year":"2017","unstructured":"P.O. Pietarinen, C.A. Eide, P. Ayuda-Dur\u00e1n, S. Potdar, H. Kuusanm\u00e4ki, E.I. Andersson, J.P. Mpindi, T. Pemovska, M. Kontro, C.A. Heckman, O. Kallioniemi, K. Wennerberg, H. Hjorth-Hansen, B.J. Druker, J.M. Enserink, J.W. Tyner, S. Mustjoki, K. Porkka, Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors. Oncotarget 8, 22606\u201322615 (2017)","journal-title":"Oncotarget"},{"key":"379_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003226","volume":"9","author":"J Tang","year":"2013","unstructured":"J. Tang, L. Karhinen, T. Xu, A. Szwajda, B. Yadav, K. Wennerberg, T. Aittokallio, Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways. PLoS Comput. Biol. 9, e1003226 (2013)","journal-title":"PLoS Comput. Biol."},{"key":"379_CR28","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1038\/srep05193","volume":"4","author":"B Yadav","year":"2015","unstructured":"B. Yadav, T. Pemovska, A. Szwajda, E. Kulesskiy, M. Kontro, R. Karjalainen, M.M. Majumder, D. Malani, A. Murum\u00e4gi, J. Knowles, K. Porkka, C. Heckman, O. Kallioniemi, K. Wennerberg, T. Aittokallio, Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies. Sci. Rep. 4, 5193 (2015)","journal-title":"Sci. Rep."},{"key":"379_CR29","doi-asserted-by":"publisher","first-page":"97516","DOI":"10.18632\/oncotarget.22178","volume":"8","author":"H Kuusanm\u00e4ki","year":"2017","unstructured":"H. Kuusanm\u00e4ki, O. Dufva, E. Parri, A.J. van Adrichem, H. Rajala, M.M. Majumder, B. Yadav, A. Parsons, W.C. Chan, K. Wennerberg, S. Mustjoki, C.A. Heckman, Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK\/STAT3 signaling. Oncotarget 8, 97516\u201397527 (2017)","journal-title":"Oncotarget"},{"key":"379_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ygyno.2013.05.003","volume":"130","author":"R Demsky","year":"2013","unstructured":"R. Demsky, J. McCuaig, M. Maganti, K.J. Murphy, B. Rosen, S.R. Armel, Keeping it simple: Genetics referrals for all invasive serous ovarian cancers. Gynecol. Oncol. 130, 329\u2013333 (2013)","journal-title":"Gynecol. Oncol."},{"key":"379_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/IGC.0b013e3182392714","volume":"22","author":"A Lanceley","year":"2012","unstructured":"A. Lanceley, Z. Eagle, G. Ogden, S. Gessler, K. Razvi, J.A. Ledermann, L. Side, Family history and women with ovarian cancer. Int. J. Gynecol. Cancer 22, 254\u2013259 (2012)","journal-title":"Int. J. Gynecol. Cancer"},{"key":"379_CR32","doi-asserted-by":"publisher","first-page":"29506","DOI":"10.1038\/srep29506","volume":"6","author":"A George","year":"2016","unstructured":"A. George, D. Riddell, S. Seal, S. Talukdar, S. Mahamdallie, E. Ruark, V. Cloke, I. Slade, Z. Kemp, M. Gore, A. Strydom, S. Banerjee, H. Hanson, N. Rahman, Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients. Sci. Rep. 6, 29506 (2016)","journal-title":"Sci. Rep."},{"key":"379_CR33","unstructured":"Guidance and guidelines, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. NICE [Internet]. United Kingdom, National Institute for Health and Clinical Excellence. \n                    https:\/\/www.nice.org.uk\/guidance\/cg164\/chapter\/Recommendations\n                    \n                   Accessed 11 December 2017"},{"key":"379_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12687-016-0266-4","volume":"7","author":"I Slade","year":"2016","unstructured":"I. Slade, H. Hanson, A. George, K. Kohut, A. Strydom, S. Wordsworth, N. Rahman, A cost analysis of a cancer genetic service model in the UK. J. Community Genet. 7, 185\u2013194 (2016)","journal-title":"J. Community Genet."},{"key":"379_CR35","unstructured":"Assembly of the Republic, in Di\u00e1rio da Rep\u00fablica Eletr\u00f3nico, Legisla\u00e7\u00e3o, Lei n.o 12\/2005- Di\u00e1rio da Rep\u00fablica n.o 18\/2005, S\u00e9rie I-A de 2005\u201301-26- DRE. 606\u2013611 [Internet]. Portugal, Di\u00e1rio da Rep\u00fablica Eletr\u00f3nico. \n                    https:\/\/dre.pt\/web\/guest\/pesquisa\/-\/search\/624463\/details\/normal?_search_WAR_drefrontofficeportlet_print_preview=print-preview\n                    \n                   Accessed 11 December 2017"},{"key":"379_CR36","unstructured":"Assembly of the Republic, in Di\u00e1rio da Rep\u00fablica Eletr\u00f3nico, Legisla\u00e7\u00e3o, Decreto-Lei n.o 131\/2014 \u2013 Minist\u00e9rio da Sa\u00fade\u2013Regulamenta a Lei n.o 12\/2005, de 26 de janeiro [Internet]. Portugal, Di\u00e1rio da Rep\u00fablica Eletr\u00f3nico. http:\/\/direitodamedicina.sanchoeassociados.com\/arquivo\/decreto-lei-n-o-1312014-ministerio-da-saude-regulamenta-a-lei-n-o-122005-de-26-de-janeiro-no-que-se-refere-a-protecao-e-confidencialidade-da-informacao-genetica-as-bases-de-da\/ Accessed 11 December 2017"},{"key":"379_CR37","unstructured":"Commissioner of the Press Announcements in FDA, U.S. Food and Drug, Press Announcements. FDA approves first cancer treatment for any solid tumor with a specific genetic feature [Internet]. USA, FDA. \n                    https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm560167.htm\n                    \n                   Accessed 11 December 2017"},{"key":"379_CR38","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"D.T. Le, J.N. Uram, H. Wang, B.R. Bartlett, H. Kemberling, A.D. Eyring, A.D. Skora, B.S. Luber, N.S. Azad, D. Laheru, B. Biedrzycki, R.C. Donehower, A. Zaheer, G.A. Fisher, T.S. Crocenzi, J.J. Lee, S.M. Duffy, R.M. Goldberg, A. de la Chapelle, M. Koshiji, F. Bhaijee, T. Huebner, R.H. Hruban, L.D. Wood, N. Cuka, D.M. Pardoll, N. Papadopoulos, K.W. Kinzler, S. Zhou, T.C. Cornish, J.M. Taube, R.A. Anders, J.R. Eshleman, B. Vogelstein, L.A. Diaz, PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509\u20132520 (2015)","journal-title":"N. Engl. J. Med."},{"key":"379_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"D.T. Le, J.N. Durham, K.N. Smith, H. Wang, B.R. Bartlett, L.K. Aulakh, S. Lu, H. Kemberling, C. Wilt, B.S. Luber, F. Wong, N.S. Azad, A.A. Rucki, D. Laheru, R. Donehower, A. Zaheer, G.A. Fisher, T.S. Crocenzi, J.J. Lee, T.F. Greten, A.G. Duffy, K.K. Ciombor, A.D. Eyring, B.H. Lam, A. Joe, S.P. Kang, M. Holdhoff, L. Danilova, L. Cope, C. Meyer, S. Zhou, R.M. Goldberg, D.K. Armstrong, K.M. Bever, A.N. Fader, J. Taube, F. Housseau, D. Spetzler, N. Xiao, D.M. Pardoll, N. Papadopoulos, K.W. Kinzler, J.R. Eshleman, B. Vogelstein, R.A. Anders, L.A. Diaz, Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413 (2017)","journal-title":"Science"},{"key":"379_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"M. Robson, S.A. Im, E. Senkus, B. Xu, S.M. Domchek, N. Masuda, S. Delaloge, W. Li, N. Tung, A. Armstrong, W. Wu, C. Goessl, S. Runswick, P. Conte, Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N. Engl. J. Med. 377, 523\u2013533 (2017)","journal-title":"N. Engl. J. Med."},{"key":"379_CR41","unstructured":"European public assessment report (EPAR) in European Medicines Agency (EMA), Science Medicines Health, Human Medicine. Lynparza [Internet]. United Kingdom, EMA. \n                    http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/003726\/human_med_001831.jsp&mid=WC0b01ac058001d124\n                    \n                   Accessed 15 December 2017"},{"key":"379_CR42","unstructured":"F.R. Vogenberg, C. Isaacson Barash, M. Pursel, Personalized medicine: part 1: evolution and development into theranostics. P & T 35, 560\u2013576 (2010)"},{"key":"379_CR43","unstructured":"Servi\u00e7o Nacional de Sa\u00fade (SNS), Medicina personalizada na Europa [Internet]. Portugal, SNS. \n                    https:\/\/www.sns.gov.pt\/noticias\/2017\/10\/20\/medicina-personalizada-na-europa\/\n                    \n                   Accessed 18 December 2017"},{"key":"379_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/PPA.S38578","volume":"7","author":"NL Bragazzi","year":"2013","unstructured":"N.L. Bragazzi, From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and \"augmented\" medicine: some considerations on Salvatore Iaconesi\u2019s clinical story. Patient Prefer Adherence 7, 353\u2013359 (2013)","journal-title":"Patient Prefer Adherence"},{"key":"379_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/msj.20005","volume":"74","author":"EP Bottinger","year":"2007","unstructured":"E.P. Bottinger, Foundations, promises and uncertainties of personalized medicine. Mt Sinai J. Med. 74, 15\u201321 (2007)","journal-title":"Mt Sinai J. Med."},{"key":"379_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMp1006304","volume":"363","author":"MA Hamburg","year":"2010","unstructured":"M.A. Hamburg, F.S. Collins, The path to personalized medicine. N. Engl. J. Med. 363, 301\u2013304 (2010)","journal-title":"N. Engl. J. Med."},{"key":"379_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1651-2227.2011.02224.x","volume":"100","author":"MF Haward","year":"2011","unstructured":"M.F. Haward, J.M. Lorenz, Communicating risk under conditions of uncertainty: not as simple as it may seem. Acta Paediatr. 100, 651\u2013652 (2011)","journal-title":"Acta Paediatr."},{"key":"379_CR48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/520609a","volume":"520","author":"NJ Schork","year":"2015","unstructured":"N.J. Schork, Personalized medicine: time for one-person trials. Nature 520, 609\u2013611 (2015)","journal-title":"Nature"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-018-0379-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T05:11:57Z","timestamp":1554786717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-018-0379-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1007\/s13402-018-0379-3","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"21 March 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}